| 1 | 25194 | Impact of Granulocyte colony-stimulating factor (filgrastim) on absolute neutrophil count after receiving filgrastim in cancer patients with febrile neutropenia: A 5-year retrospective cohort study (2025-07-01) 10.18549/PharmPract.2025.3.3283
| Uitrakul, Suriyon (F)   Majam, Teerapat (C)   Jantataeme, Apichaya (Co)   Jeenchaona, Kanokwan (Co)   Waeyusoh, Nurasikeen (Co)   Art-hanying, Lalana (Co)    | Pharmacy Practice (Q1), Volume 23, Issue 2025 | | Majam, Teerapat เคลมผลงาน 1:1 ในปี 2025 | Published | Approved | |
| 2 | 24843 | Impact of Granulocyte colony-stimulating factor (filgrastim) on absolute neutrophil count after receiving filgrastim in cancer patients with febrile neutropenia: A 5-year retrospective cohort study. ()
| Uitrakul, Suriyon (F)   Majam, Teerapat (C)   Jantataeme, Apichaya (Co)   Jeenchaona, Kanokwan (Co)   Waeyusoh, Nurasikeen (Co)   Art-hanying, Lalana (Co)    | Pharmacy Practice (Q1) | | | Accepted | Pending Approval | |
| 3 | 24842 | Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer (2024-12-01) 10.1038/s41598-024-77935-0
| Trachu, Narumol (F)   Udomsinprasert, Wanvisa (C)   Reungwetwattana, Thanyanan (Co)   Meanwatthana, Jennis (Co)   Sukasem, Chonlaphat (Co)   Saengsiwaritt, Wacharapol (Co)   Jittikoon, Jiraphun (Co)    | Scientific Reports (Q1), Volume 14, Issue 1 | | | Published | Approved | |
| 4 | 23372 | CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients (2023-01-01) 10.3389/fphar.2023.1222435
| Majam, Teerapat (F)   Meanwatthana, Jennis (C)   Sukasem, Chonlaphat (Co)   Reungwetwattana, Thanyanan (Co)   Chansriwong, Phichai (Co)   Atasilp, Chalirmporn (Co)   Trachu, Narumol (Co)   Thamrongjirapat, Thanaporn (Co)   Sukprasong, Rattanaporn (Co)    | Frontiers in Pharmacology (Q1), Volume 14 | 2023 | | Published | Approved | Can be assessment in 2023 |
| 5 | 23139 | Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection (2022-10-01) 10.1177/08971900211000691
| Meanwatthana, Jennis (F)   Majam, Teerapat (Co)    | Journal of Pharmacy Practice (Q3), Volume 35, Issue 5, Pages number 752-761 | 2021 | | Published | Approved | Can't be assessed |